Fracture of hand and wrist in pediatric patients.
Conditions
Interventions
Group S: Selective forearm brachial plexus block :Selective forearm brachial plexus block with 3 mL of 0.2% ropivacaine targeting the ulnar nerve, and/or median nerve, and/or radial nerve under ultras
Group B: Conventional axillary brachial plexus block:Conventional axillary brachial plexus block with 0.2% ropivacaine at 0.5 mL/kg (maximum 15 mL) under ultrasound guidance.
Sponsors
Wuhan Orthopaedics Hospital of Integrated Traditional Chinese and Western Medicine (The Affiliated Hospital of Wuhan Sports University)
Eligibility
Sex/Gender
All
Age
7 Years to 14 Years
Inclusion criteria
Inclusion criteria: 1. Pediatric surgery involving the wrist and more distal sites. 2. Age 7–14 years. 3. ASA Physical Status Classification I–II.
Exclusion criteria
Exclusion criteria: 1. History of chronic brachial plexus neuropathy or injury; 2. Infection or tumor at the puncture site; 3. Previous history of upper limb surgery; 4. Tolerance or allergy to anesthetic drugs; 5. Combined with surgical contraindications, severe internal medical diseases, functional impairment or organic diseases of vital organs; 6. Combined with neurological disorders, coagulation or immune dysfunction; 7. Inability to cooperate with and complete the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset time of sensory block; Postoperative muscle strength recovery;Nerve Block Operation Time;NRS Pain Scores at Various Postoperative Time Points;Duration of Analgesia;Time for muscle strength to recover to grade 5; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse events;PQRS Scores at Various Postoperative Time Points; | — |
Countries
China
Contacts
Public ContactJingjing Yang
Wuhan Orthopaedics Hospital of Integrated Traditional Chinese and Western Medicine(The Affiliated Hospital of Wuhan Sports University)
Outcome results
None listed